CHRISTINA LAKE CANNABIS (CLB) - Net Assets
Based on the latest financial reports, CHRISTINA LAKE CANNABIS (CLB) has net assets worth €16.84 Million EUR (≈ $19.69 Million USD) as of November 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.02 Million ≈ $32.76 Million USD) and total liabilities (€11.18 Million ≈ $13.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See CHRISTINA LAKE CANNABIS (CLB) net asset quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €16.84 Million |
| % of Total Assets | 60.11% |
| Annual Growth Rate | 3.49% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.96 |
CHRISTINA LAKE CANNABIS - Net Assets Trend (2021–2024)
This chart illustrates how CHRISTINA LAKE CANNABIS's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see CLB company net worth.
Annual Net Assets for CHRISTINA LAKE CANNABIS (2021–2024)
The table below shows the annual net assets of CHRISTINA LAKE CANNABIS from 2021 to 2024. Also explore CHRISTINA LAKE CANNABIS annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-11-30 | €10.79 Million ≈ $12.62 Million |
+44.67% |
| 2023-11-30 | €7.46 Million ≈ $8.72 Million |
-33.01% |
| 2022-11-30 | €11.14 Million ≈ $13.02 Million |
+14.36% |
| 2021-11-30 | €9.74 Million ≈ $11.39 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CHRISTINA LAKE CANNABIS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 449537100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €28.24 Million | 261.65% |
| Total Equity | €10.79 Million | 100.00% |
CHRISTINA LAKE CANNABIS Competitors by Market Cap
The table below lists competitors of CHRISTINA LAKE CANNABIS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tongaat
JSE:TON
|
$290.09K |
|
Oxurion NV
BR:OXUR
|
$290.33K |
|
Digital 9 Infrastructure PLC
LSE:DGI9
|
$291.36K |
|
TTA Holdings Ltd
AU:TTA
|
$291.71K |
|
Multistack International Ltd
AU:MSI
|
$289.33K |
|
Global PVQ SE
HM:QCE
|
$288.63K |
|
Sino-German United AG
F:SGU
|
$288.00K |
|
Elixxer Ltd
V:ELXR
|
$287.08K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CHRISTINA LAKE CANNABIS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,461,508 to 10,794,256, a change of 3,332,748 (44.7%).
- Net income of 864,995 contributed positively to equity growth.
- New share issuances of 1,869,901 increased equity.
- Other factors increased equity by 597,852.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €865.00K | +8.01% |
| Share Issuances | €1.87 Million | +17.32% |
| Other Changes | €597.85K | +5.54% |
| Total Change | €- | 44.67% |
Book Value vs Market Value Analysis
This analysis compares CHRISTINA LAKE CANNABIS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-11-30 | €0.08 | €0.00 | x |
| 2022-11-30 | €0.09 | €0.00 | x |
| 2023-11-30 | €0.06 | €0.00 | x |
| 2024-11-30 | €0.06 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CHRISTINA LAKE CANNABIS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.01%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.36%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.16x
- Recent ROE (8.01%) is above the historical average (-34.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -73.34% | -196.59% | 0.19x | 1.96x | €-8.12 Million |
| 2022 | -18.21% | -20.13% | 0.54x | 1.69x | €-3.14 Million |
| 2023 | -55.38% | -35.08% | 0.74x | 2.14x | €-4.88 Million |
| 2024 | 8.01% | 6.36% | 0.58x | 2.16x | €-214.43K |
Industry Comparison
This section compares CHRISTINA LAKE CANNABIS's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $8,841,324,832
- Average return on equity (ROE) among peers: -32.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CHRISTINA LAKE CANNABIS (CLB) | €16.84 Million | -73.34% | 0.66x | $290.05K |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $59.93 Billion | 4.62% | 0.96x | $1.21 Billion |
| PEPTONIC MEDICAL (28L) | $48.55 Million | -123.64% | 0.45x | $5.52 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $5.52 Billion | 11.33% | 0.42x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| HANSOH PHARMAC. HD-00001 (3KY) | $22.65 Billion | 11.41% | 0.32x | $22.06 Billion |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $-2.95 Million | 0.00% | 0.00x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $252.47 Million | -46.64% | 0.59x | $136.75 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-8.51 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-815.79K | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $17.35 Million | -23.30% | 0.22x | $6.62 Million |
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more